Table 2.
Variable | OS | RFS | ||||||
---|---|---|---|---|---|---|---|---|
P‐value | HR | 95% CI for HR | P‐value | HR | 95% CI for HR | |||
Lower | Upper | Lower | Upper | |||||
S17 signature | <0·001 | 1·485 | 1·186 | 1·860 | <0·001 | 1·834 | 1·326 | 2·536 |
Age | <0·001 | 1·291 | 1·197 | 1·391 | <0·001 | 1·198 | 1·081 | 1·327 |
ELN2a | <0·001 | 2·395 | 1·743 | 3·291 | <0·001 | 3·147 | 2·124 | 4·663 |
ELN3a | <0·001 | 2·395 | 1·732 | 3·312 | <0·001 | 2·153 | 1·405 | 3·299 |
ELN4a | <0·001 | 3·306 | 2·376 | 4·599 | <0·001 | 6·401 | 4·027 | 10·175 |
OS, overall survival; RFS, relapse‐free survival; HR, Hazard ratio.
The ELN2, ELN3, and ELN4 indicate the corresponding genetic ELN groups compared to the ELN1 group, respectively.